4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-22-055548
Chief Financial Officer acquired 33,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Byam Rebecca Chief Financial Officer | 2022-11-02 | Option exercise | +33,750 | $0.14 | $4,725 | 361,702 | D |
| Derivatives | |||||||
| Byam Rebecca Chief Financial Officer | 2022-11-02 | Option exercise · Stock Option Grant (Right to Buy) | −33,750 | 47,249 | D | ||
Loading xslF345X03/doc4.xml…